These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 25928649)
1. Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. Tanner NT; Gebregziabher M; Hughes Halbert C; Payne E; Egede LE; Silvestri GA Am J Respir Crit Care Med; 2015 Jul; 192(2):200-8. PubMed ID: 25928649 [TBL] [Abstract][Full Text] [Related]
2. Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality. Prosper AE; Inoue K; Brown K; Bui AAT; Aberle D; Hsu W JAMA Netw Open; 2021 Aug; 4(8):e2119629. PubMed ID: 34427681 [TBL] [Abstract][Full Text] [Related]
3. Racial disparities in eligibility for low-dose computed tomography lung cancer screening among older adults with a history of smoking. Li CC; Matthews AK; Rywant MM; Hallgren E; Shah RC Cancer Causes Control; 2019 Mar; 30(3):235-240. PubMed ID: 30377905 [TBL] [Abstract][Full Text] [Related]
4. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Tanner NT; Kanodra NM; Gebregziabher M; Payne E; Halbert CH; Warren GW; Egede LE; Silvestri GA Am J Respir Crit Care Med; 2016 Mar; 193(5):534-41. PubMed ID: 26502000 [TBL] [Abstract][Full Text] [Related]
5. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial. Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856 [TBL] [Abstract][Full Text] [Related]
6. Racial Differences in Smoking-related Disease Risk Perceptions Among Adults Completing Lung Cancer Screening: Follow-up Results from the ACRIN/NLST Ancillary Study. Perez GK; Gareen IF; Sicks J; Lathan C; Carr A; Kumar P; Ponzani C; Hyland K; Park ER J Racial Ethn Health Disparities; 2019 Aug; 6(4):676-685. PubMed ID: 30737732 [TBL] [Abstract][Full Text] [Related]
7. Evaluating Potential Racial Inequities in Low-dose Computed Tomography Screening for Lung Cancer. Richmond J; Mbah OM; Dard SZ; Jordan LC; Cools KS; Samuel CA; Khan JM; Manning MA J Natl Med Assoc; 2020 Apr; 112(2):209-214. PubMed ID: 32067762 [TBL] [Abstract][Full Text] [Related]
9. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468 [TBL] [Abstract][Full Text] [Related]
10. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Pinsky PF; Gierada DS; Hocking W; Patz EF; Kramer BS Ann Intern Med; 2014 Nov; 161(9):627-33. PubMed ID: 25199624 [TBL] [Abstract][Full Text] [Related]
11. Reply: Lung Cancer Susceptibility, Ethnicity, and the Benefits of Computed Tomography Screening. Ruparel M; Navani N Am J Respir Crit Care Med; 2015 Dec; 192(11):1396. PubMed ID: 26623690 [No Abstract] [Full Text] [Related]
12. Improving selection criteria for lung cancer screening. The potential role of emphysema. Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622 [TBL] [Abstract][Full Text] [Related]
13. Potential Racial Disparities Using Current Lung Cancer Screening Guidelines. Annangi S; Nutalapati S; Foreman MG; Pillai R; Flenaugh EL J Racial Ethn Health Disparities; 2019 Feb; 6(1):22-26. PubMed ID: 29729002 [TBL] [Abstract][Full Text] [Related]
14. Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial. Kumar P; Gareen IF; Lathan C; Sicks JD; Perez GK; Hyland KA; Park ER Oncologist; 2016 Jan; 21(1):40-9. PubMed ID: 26712960 [TBL] [Abstract][Full Text] [Related]
15. Lung Cancer Susceptibility, Ethnicity, and the Benefits of Computed Tomography Screening. Hopkins RJ; Duan F; Young RP Am J Respir Crit Care Med; 2015 Dec; 192(11):1394-6. PubMed ID: 26623689 [No Abstract] [Full Text] [Related]
16. Surgical Disparities Among Patients With Stage I Lung Cancer in the National Lung Screening Trial. Balekian AA; Wisnivesky JP; Gould MK Chest; 2019 Jan; 155(1):44-52. PubMed ID: 30056040 [TBL] [Abstract][Full Text] [Related]
17. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. Aberle DR; Abtin F; Brown K J Clin Oncol; 2013 Mar; 31(8):1002-8. PubMed ID: 23401434 [TBL] [Abstract][Full Text] [Related]
18. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Pinsky PF; Church TR; Izmirlian G; Kramer BS Cancer; 2013 Nov; 119(22):3976-83. PubMed ID: 24037918 [TBL] [Abstract][Full Text] [Related]
19. Fulfilling the Dream. Toward Reducing Inequalities in Lung Cancer Screening. Ruparel M; Navani N Am J Respir Crit Care Med; 2015 Jul; 192(2):125-7. PubMed ID: 26177167 [No Abstract] [Full Text] [Related]